← Home

Core concept

Remote patient monitoring in oncology

Remote oncology monitoring is an organised pathway for observing change between visits. Device data and patient-reported symptoms follow a predefined protocol; an authorised professional reviews meaningful signals rather than delegating clinical decisions to software.

Audience
For oncology teams, researchers and healthcare leaders
Status
Research information, not medical advice
Editorial
NPO NT project team; scientific concept by Dr Artem Poltoratskiy
Review
No independent external medical review of this edition is claimed
Updated
Reviewed 19 August 2026
01

The monitoring pathway

  • Patient-reported symptoms and functional impact.
  • Only the wearable measures that a selected device can actually provide.
  • A personal baseline, a defined observation window and a prespecified signal rule.
  • A review queue, contact pathway and documented human action.
02

What it is not

A stream of measurements is not a diagnosis, an emergency service or a telemedicine consultation by itself. A safe pathway begins with a clinical question, responsibilities and response time—not with a dashboard.

03

What a pilot should test

  • Data completeness and missingness.
  • Participant and staff burden.
  • Signal frequency, review time and false alerts.
  • Only prespecified feasibility, organisational or clinical endpoints.

Sources and traceability

Evidence used for this page

External sources remain responsible for their content. This page does not replace clinical guidance, legal advice or device-specific validation.